Literature DB >> 16439845

Turner syndrome, insulin sensitivity and growth hormone treatment.

Laura Mazzanti1, Rosalba Bergamaschi, Laura Castiglioni, Franco Zappulla, Piero Pirazzoli, Alessandro Cicognani.   

Abstract

Mild insulin resistance appears to be an early metabolic defect in girls with Turner syndrome (TS). Impaired glucose tolerance has been reported in 10-34% of patients with TS, and type 2 diabetes mellitus is 2-4 times more common and occurs at a younger age in girls with TS than in the general population. In a mixed longitudinal and cross-sectional study, we analysed carbohydrate tolerance and insulin sensitivity in 46 children and adolescents with TS who reached their final height after long-term treatment (mean 6.3 +/- 2.5 years) with growth hormone (GH: 0.33 mg/kg/week [0.05 mg/kg/day]), and in 36 of these patients who were followed-up after the cessation of GH therapy (mean follow-up, 2.6 +/- 2.5 years; range, 1-9.5 years). Patients with TS were compared with an age-matched female control group. Insulin sensitivity appeared to be lower in patients with TS than in controls, even before the start of GH therapy. As in controls, insulin sensitivity decreased with age in patients with TS, and levels were lower in those aged >12 years than in those aged <12 years. GH therapy resulted in good catch-up growth in patients with TS, with final height significantly higher than projected height evaluated before the initiation of GH therapy. Insulin sensitivity increased after 7-8 years of therapy and, on the cessation of GH therapy, returned to pre-treatment levels. The increase in insulin sensitivity seen on the cessation of GH therapy appeared to be influenced negatively by body mass index and triglyceride levels, and correlated positively with the number of years since cessation of GH therapy. As in the general population, excess weight and an abnormal lipid profile, in particular excess triglyceride levels, worsened insulin sensitivity. In conclusion, our study confirms that GH therapy reduces insulin sensitivity, but at its cessation there is a return to pre-therapy values. We therefore report a progressive improvement in carbohydrate tolerance and insulin function in patients with TS, despite an increase in age. Copyright (c) 2005 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16439845     DOI: 10.1159/000089318

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  7 in total

Review 1.  Turner syndrome.

Authors:  Shelli R Kesler
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2007-07

2.  New insights into the comorbid conditions of Turner syndrome: results from a long-term monocentric cohort study.

Authors:  A Gambineri; E Scarano; P Rucci; A Perri; F Tamburrino; P Altieri; F Corzani; C Cecchetti; P Dionese; E Belardinelli; D Ibarra-Gasparini; S Menabò; V Vicennati; A Repaci; G di Dalmazi; C Pelusi; G Zavatta; A Virdi; I Neri; F Fanelli; L Mazzanti; U Pagotto
Journal:  J Endocrinol Invest       Date:  2022-07-30       Impact factor: 5.467

3.  Increased Prevalence of Beta-Cell Dysfunction despite Normal HbA1c in Youth and Young Adults with Turner Syndrome.

Authors:  Nicole Sheanon; Deborah Elder; Jane Khoury; Lori Casnellie; Iris Gutmark-Little; Joseph Cernich; Phillipe F Backeljauw
Journal:  Horm Res Paediatr       Date:  2021-10-15       Impact factor: 4.275

4.  Insulin resistance in adolescents with Turner syndrome is comparable to obese peers, but the overall metabolic risk is lower due to unknown mechanism.

Authors:  M Wojcik; D Janus; A Zygmunt-Gorska; J B Starzyk
Journal:  J Endocrinol Invest       Date:  2014-10-11       Impact factor: 4.256

Review 5.  Cardiometabolic and vascular risks in young and adolescent girls with Turner syndrome.

Authors:  Meenal Mavinkurve; Clodagh S O'Gorman
Journal:  BBA Clin       Date:  2015-04-30

6.  Insulin Sensitivity and Pancreatic β-Cell Function in Ecuadorian Women With Turner Syndrome.

Authors:  Francisco Álvarez-Nava; Daniela Bastidas; Marcia Racines-Orbe; Jéssica Guarderas
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-07       Impact factor: 5.555

7.  Epicardial and Perihepatic Fat as Cardiometabolic Risk Predictors in Girls with Turner Syndrome: A Cardiac Magnetic Resonance Study

Authors:  Nanees A. Salem; Nihal M. Batouty; Ahmed M. Tawfik; Donia M. Sobh; Basma Gadelhak; Shimaa R. Hendawy; Wafaa Laimon
Journal:  J Clin Res Pediatr Endocrinol       Date:  2021-05-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.